Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Denosumab in Subjects With Giant Cell Rich Tumors of Bone

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03605199
Recruitment Status : Recruiting
First Posted : July 30, 2018
Last Update Posted : July 30, 2018
Sponsor:
Collaborator:
Amgen
Information provided by (Responsible Party):
HansGelderblom, Leiden University Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : June 2021
  Estimated Study Completion Date : June 2023